The overall thrust in his research program is the impact of nanomaterials on the structure, function and delivery of nucleic acids and proteins.
His group has a keen interest in the anti-cancer properties of nanoparticles when combined with nucleic acid therapeutics (NAT) and anticancer protein (ACP) and also studies the biochemical and immunological activity of nanoparticles and their application as new fluorescence or bioluminescence-enhanced imaging agents.
Our lab studies the interaction, stabilization and delivery of therapeutic RNA, mRNA vaccine and antiviral/antimicrobial peptide by nanoparticles.
Research:
- Anatomy & Physiology – Studies the use of RNA nanotechnology to deliver splice switching oligonucleotides and aptamer RNA into cancer cells
Areas of expertise:
- Nanomedicine
- Biological interactions with nanoparticles
